Crossref
Quality versus queasy: neurokinin 1 receptor antagonist use in moderately emetogenic chemotherapy
The Journal of Community and Supportive Oncology · 2016
DOI: 10.12788/j.sder.0274 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Community and Supportive Oncology, 2016. Verfasst von Jayan Nair und 4 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nair, J., Curley, B., Fong, R., Hwang, J., & Byrne, M. (2016). Quality versus queasy: neurokinin 1 receptor antagonist use in moderately emetogenic chemotherapy. The Journal of Community and Supportive Oncology. https://doi.org/10.12788/j.sder.0274
Vancouver
Nair J, Curley B, Fong R, Hwang J, Byrne M. Quality versus queasy: neurokinin 1 receptor antagonist use in moderately emetogenic chemotherapy. The Journal of Community and Supportive Oncology. 2016. doi:10.12788/j.sder.0274
BibTeX
@article{Nair2016,
author = {Nair, Jayan and Curley, Brendan and Fong, Richard and Hwang, Jimmy and Byrne, Michael},
title = {Quality versus queasy: neurokinin 1 receptor antagonist use in moderately emetogenic chemotherapy},
journal = {The Journal of Community and Supportive Oncology},
year = {2016},
doi = {10.12788/j.sder.0274}
}
EUVIMED